5.46
0.17 (3.21%)
0.17 (3.21%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 1,374,409 |
|
|||||
| News | - | ||||||
| Day High | 5.74 | Low High |
|||||
| Day Low | 5.23 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Prelude Therapeutics Inc | PRLD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.17 | 3.21% | 5.46 | 18:00:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.31 | 5.23 | 5.74 | 5.46 | 5.29 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,836 | 1,374,409 | $ 5.51 | $ 7,567,863 | - | 3.87 - 43.5499 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:17:09 | formt | 1,899 | $ 5.46 | USD |
Period:
Draw Mode:
Prelude Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 260.42M | 47.70M | 6.68M | $ - | $ - | -2.42 | -2.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 616.50k | 4.30% |
Prelude Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRLD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.44 | 5.74 | 4.3328 | 4.98 | 212,523 | 1.02 | 22.97% |
| 1 Month | 4.52 | 5.74 | 4.165 | 4.61 | 211,049 | 0.94 | 20.8% |
| 3 Months | 6.89 | 7.96 | 3.87 | 5.26 | 270,580 | -1.43 | -20.75% |
| 6 Months | 13.67 | 13.735 | 3.87 | 7.55 | 265,610 | -8.21 | -60.06% |
| 1 Year | 33.69 | 43.5499 | 3.87 | 16.54 | 334,347 | -28.23 | -83.79% |
| 3 Years | 25.76 | 95.375 | 3.87 | 27.31 | 281,418 | -20.30 | -78.8% |
| 5 Years | 25.76 | 95.375 | 3.87 | 27.31 | 281,418 | -20.30 | -78.8% |
Prelude Therapeutics Description
| Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. |